MDBH MDB CAPITAL HOLDINGS LLC

PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership

PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership



Sarah Cork Ph.D. - Patent Attorney

Dallas, TX, Sept. 24, 2025 (GLOBE NEWSWIRE) -- PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is pleased to announce that Dr. Sarah Cork is collaborating with the firm as a Senior Patent Attorney. Her arrival underscores PatentVest’s continued growth in the life sciences sector and strengthens its ability to deliver sophisticated intellectual property strategies that drive competitive advantage for clients.

Dr. Cork brings more than a decade of experience advising biotechnology, pharmaceutical, and medical device companies on complex intellectual property matters. With a Ph.D. in Neuroscience, she counsels clients on a wide range of sophisticated issues involving recombinant technology, biologic and small-molecule drugs, immunotherapies, gene therapy, medical devices, and AI-enabled precision medicine, with a focus on translational drug discovery. Her legal practice combines scientific expertise with extensive experience in patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses. She has advised clients ranging from venture-backed startups developing first-in-class therapies to global enterprises defending multibillion-dollar portfolios.

Dr. Cork’s cases under the Biologics Price Competition and Innovation Act (BPCIA), early at-risk launches.  Her litigation background also spans Hatch-Waxman (ANDA) matters, post-grant proceedings, patent inventorship disputes, and drug product liability cases.

“Sarah’s arrival is a major win for our clients,” said Javier Chamorro, COO of PatentVest. “Her unique combination of deep scientific knowledge and proven litigation experience equips us to guide innovators through the most complex IP challenges—from protecting groundbreaking biologics to navigating regulatory pathways. Adding Sarah to our team strengthens PatentVest’s position as a trusted partner for life sciences companies and aligns with our broader mission to build enduring value for our clients and stakeholders.”

Beyond her legal practice, Dr. Cork is an active leader in the intellectual property and life sciences communities. She currently serves as the President of the Los Angeles Intellectual Property Law Association, is a member of the Pasadena Angels investor group, contributes as an SBIR grant reviewer, and entrepreneurs in life sciences incubators and accelerators.

About PatentVest

PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and deep technical expertise, PatentVest delivers actionable insights that protect innovation and empower clients to build lasting market leadership.

For more information or inquiries, please contact .

Attachment



EN
24/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MDB CAPITAL HOLDINGS LLC

 PRESS RELEASE

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Le...

MDB Capital Holdings Provides 2025 Full Year Update and Shareholder Letter Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, March 31, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-defining disruptive technology companies, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025. More Detailed Information 2025 Annual Shareholder Letter . Form 10-K . Key Assets and Strategic Developments eXoZymes (NASDAQ: EXOZ): MDB holds appr...

 PRESS RELEASE

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Ra...

PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Next Pillar of Obesity Medicine.” The report provides a comprehensive analysis of the rapidly evolving amylin drug landscape, a mechanism once considered commercially unviable that is now at the center of global pharmaceutical strategy. Over the past eighteen months, more than $19 billion i...

 PRESS RELEASE

PatentVest Highlights New Legal Article on AI Patenting Strategy by Se...

PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspectives on intellectual property strategy, emerging technology, and innovation-driven industries. The IP Legal Insights section serves as a resource for founders, executives, and investors seeking to better understand how intellectual property decisions impact innovation, competitive positioning...

 PRESS RELEASE

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stak...

PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services IP Strategy and Legal firm backs vascular technology innovator with both expertise and capital commitment Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest, a leading provider of IP Strategy and Legal services, today announced a strategic engagement with Life Seal Vascular and disclosed that it has accepted equity in the company as partial consideration for its services. The arrangement reflects PatentVest's conviction in Life Seal Vascular's underlying technology and...

 PRESS RELEASE

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results...

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call. Christopher Marlett, CEO and Co-Founde...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch